Loss Ratio (Annual)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Halozyme Therapeutics, Inc. (HALO) Loss Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$1.02B
Net Income	$444.09M
Cost of Goods Sold	$159.42M
Gross Profit	$855.91M
Operating Expenses	$463.85M
Operating Income	$551.48M
Non-Operating Income/Expense	$5.66M
Pre-Tax Income	$557.13M
Normalized Pre-Tax Income	$557.13M
Income after Taxes	$444.09M
Income from Continuous Operations	$444.09M
Consolidated Net Income/Loss	$444.09M
Normalized Income after Taxes	$444.09M
EBIT	$551.48M
EBITDA	$629.22M
Weighted-Average Shares Outstanding (Basic)	126.83M
Weighted-Average Shares Outstanding (Diluted)	129.42M
Earnings per Share (EPS) (Basic)	$3.50
Earnings per Share (EPS) (Diluted)	$3.43
Balance Sheet Financials
Current Assets	$1.09B
Property, Plant, and Equipment	$75.03M
Long-Term Assets	$978.14M
Total Assets	$2.06B
Current Liabilities	$139.10M
Long-Term Debt	$1.51B
Long-Term Liabilities	$1.56B
Total Liabilities	$1.70B
Common Equity	$363.82M
Tangible Shareholders Equity	$-454.83M
Shareholders Equity	$363.82M
Common Shares Outstanding	123.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$479.06M
Cash Flow from Investing Activities	$-262.72M
Cash Flow from Financial Activities	$-218.86M
Beginning Cash	$118.37M
End Cash	$115.85M
Increase/Decrease in Cash	$-2.52M
Stock-Based Compensation	$43.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.80
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.81
Debt to Equity Ratio	4.14
Gross Margin	84.30%
Operating Margin	54.32%
EBIT Margin	54.32%
EBITDA Margin	61.97%
Pre-Tax Profit Margin	54.87%
Profit Margin	43.74%
Free Cash Flow	$468.37M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	1.12
Receiveable Turnover	3.29
Days Sales in Receivables	110.89
Return on Equity	122.06%
Return on Tangible Equity	-97.64%
Return on Assets	21.52%
Return on Investments	23.75%
Book Value Per Share	$2.95
Free Cash Flow per Share	$3.62
Operating Cash Flow per Share	$3.70

Data from Zacks Investment Research, Inc.